![Marjorie Sennett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marjorie Sennett
Director/Board Member at
COGNEX CORPORATION
Net worth: 2 M $ as of 2026-05-30
Profile
Marjorie T.
Sennett is currently an Independent Director at Cognex Corp.
since 2021 and an Independent Director at Visteon Corp.
starting in 2025.
Formerly, Ms. Sennett was Managing Director at Farallon Capital Management LLC from 2002 to 2009, Independent Director at QuinStreet, Inc. from 2014 to 2018, Director at The diaTribe Foundation from 2017 to 2025, Chief Financial Officer & Senior Vice President at Amylin Pharmaceuticals, Inc. from 1997 to 1998, Chief Financial Officer & Senior Vice President at eGroups, Inc. from 1999 to 2000, and Assistant Treasurer & Associate at Bankers Trust Corp.
in 1986.
Education includes an undergraduate degree from Vanderbilt University conferred in 1982 and an MBA from Stanford Graduate School of Business conferred in 1988.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
COGNEX CORPORATION 0.02% | 2026-02-26 | 25,936 ( 0.02% ) | 2 M $ | 2026-05-30 |
VISTEON CORPORATION -.--% | 2026-04-14 | 0 ( -.--% ) | - $ | 2026-05-30 |
Marjorie Sennett active positions
| Companies | Position | Start |
|---|---|---|
| COGNEX CORPORATION | Director/Board Member | 2021-11-02 |
| VISTEON CORPORATION | Director/Board Member | 2025-07-17 |
Former positions of Marjorie Sennett
| Companies | Position | End |
|---|---|---|
Diatribe Foundation
 Diatribe Foundation Miscellaneous Commercial ServicesCommercial Services The Diatribe Foundation is a non-profit organization that aims to help people with diabetes and prediabetes. The foundation is dedicated to bringing people with type 1 and type 2 diabetes into the conversation on regulatory issues and changing the narrative around diabetes. The company has formed The Time in Range Coalition to establish time in range as an essential part of diabetic care. The goal of the program is to improve access and quality of care for people with diabetic diseases. The company is based in San Francisco. | Director/Board Member | 2024-12-31 |
| QUINSTREET, INC. | Director/Board Member | 2017-12-31 |
Farallon Capital Management LLC
 Farallon Capital Management LLC Investment ManagersFinance Farallon seeks investments across asset classes and around the world through a process of bottom-up fundamental research and analysis emphasizing capital preservation. Their investment strategies include Credit Investments, Long/Short Equity, Merger Arbitrage, Risk Arbitrage, Real Estate Investments and Direct Investments. Investment ideas compete for capital based on in-depth, critical assessment of specific risks and rewards. Risk is monitored and managed through rigorous and thorough analysis of each investment and, at the portfolio level, through risk management analytics and overlay and tail-risk hedging. | Analyst-Equity | 2009-12-30 |
eGroups, Inc.
 eGroups, Inc. Internet Software/ServicesTechnology Services Operates online portals that enables users to send and receive emails, schedule meetings, share files and photos | Director of Finance/CFO | 1999-12-31 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Director of Finance/CFO | 1997-12-31 |
Training of Marjorie Sennett
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
90
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Cognex Corp.
 Cognex Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and markets machine vision computer systems | Electronic Technology |
Farallon Capital Management LLC
Farallon Capital Management LLC Investment ManagersFinance Farallon seeks investments across asset classes and around the world through a process of bottom-up fundamental research and analysis emphasizing capital preservation. Their investment strategies include Credit Investments, Long/Short Equity, Merger Arbitrage, Risk Arbitrage, Real Estate Investments and Direct Investments. Investment ideas compete for capital based on in-depth, critical assessment of specific risks and rewards. Risk is monitored and managed through rigorous and thorough analysis of each investment and, at the portfolio level, through risk management analytics and overlay and tail-risk hedging. | Finance |
eGroups, Inc.
eGroups, Inc. Internet Software/ServicesTechnology Services Operates online portals that enables users to send and receive emails, schedule meetings, share files and photos | Technology Services |
Visteon Corp.
 Visteon Corp. Auto Parts: OEMProducer Manufacturing Designs, manufactures and supplies instrument clusters, displays, infotainment, domain controllers and driver assistance systems | Producer Manufacturing |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QuinStreet, Inc.
 QuinStreet, Inc. Advertising/Marketing ServicesCommercial Services Provides online and offline marketing services | Commercial Services |
Bankers Trust Corp.
 Bankers Trust Corp. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Diatribe Foundation
Diatribe Foundation Miscellaneous Commercial ServicesCommercial Services The Diatribe Foundation is a non-profit organization that aims to help people with diabetes and prediabetes. The foundation is dedicated to bringing people with type 1 and type 2 diabetes into the conversation on regulatory issues and changing the narrative around diabetes. The company has formed The Time in Range Coalition to establish time in range as an essential part of diabetic care. The goal of the program is to improve access and quality of care for people with diabetic diseases. The company is based in San Francisco. | Commercial Services |
- Stock Market
- Insiders
- Marjorie Sennett
